Daniel Agnew is director of corporate development at Nimble Therapeutics. Drawing on his diverse knowledge of the biotech industry, Dan supports partnering for external collaborations and academic research at Nimble, as well as devising and executing on the company’s intellectual property strategy.
Dan earned a PhD in chemical engineering from the University of Wisconsin, Madison and is a registered US patent agent with nearly a decade of experience across academia, private practice and industry. Prior to joining Nimble, Dan was a senior patent agent with Roche, where he built and cultivated an intellectual property portfolio encompassing many of the core concepts at the heart of Nimble’s proprietary platform.
Outside of work, Dan is an amateur Ultimate athlete, aficionado of french fries, avid tabletop gamer and occasional patron of live music. Dan is happiest spending time with his wife and young daughter, and has not yet given up on training the family’s wily Pomeranian.
